Clinical Trial Update: A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nivolumab with or without ipilimumab in combination with trans-arterial chemoembolization for intermediate-stage hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2024-11-26